AFRM vs BBOT · P/E 590, rev $3.22B vs $610.4M cap
Affirm Holdings Inc (AFRM) versus BridgeBio Oncology Therapeutics, Inc. (BBOT) — a side-by-side from cached financials, not a winner call.
Affirm Holdings Inc (AFRM) is a software - infrastructure company listed on US.
BridgeBio Oncology Therapeutics, Inc. (BBOT) is a biotechnology company listed on NASDAQ.
Latest reported AFRM revenue for 2025-06-30 was $3.22B. Net income was $52.2M. Revenue was up 38.8% from 2024-06-30 to 2025-06-30. AFRM currently screens at market cap $28.80B and trailing P/E 589.7.
BBOT does not have a complete income-statement cache yet.
AFRM currently screens at market cap $28.80B and trailing P/E 589.7. BBOT currently screens at market cap $610.4M.
Not investment advice. Open the AFRM and BBOT stock pages for the full models.
Not investment advice.